Research Paper Advance Articles
RGC32 promotes the progression of ccRCC by activating the NF-κB/SHP2/EGFR signaling pathway
Figure 1. RGC32 is overexpressed in ccRCC and correlated with clinicopathological features. (A) Data from TIMER2.0 and GEPIA revealed that the overexpression of RGC32 was detected in ccRCC; (B) We analyzed the relationship between RGC32 and clinical symptoms, and RGC32 was significant with Gender, Grade, T, M, N, and Stage stages; (C) We explored the predictive efficacy of RGC32 by the ROC curve.